Table 3. CircRNA in disease development and progression.

Diseases		CircRNA	References
CVD	Pathological hypertrophy and HF	HRCR	Wang et al. (2016), Wang & Wang (2015), Wang et al. (2015b)
	Atherosclerosis	CANRIL	Holdt et al. (2016)
	Cardiac senescence	Circ-Foxo3	Du et al. (2016a, 2016b)
	MI	CDRlas	Geng et al. (2016), Li et al. (2014a), Read et al. (2014)
		MFACR	Wang et al. (2017a)
Neurodegenerative diseases		CDRlas	Zhao et al. (2016)
		CircRar1	Nan et al. (2017)
Diabetes		CDRlas	Kim et al. (2017), Wang et al. (2013), Xu et al. (2015)
OA		Hsa_circ_0005105	Wu et al. (2017)
MDD		Hsa_circRNA_103636	Cui et al. (2016)
Silicosis		CircHECTD1	Zhou et al. (2018)
Cancer	GC	Hsa-circ-002059	Li et al. (2015c)
		Circrna_100269	Zhang et al. (2017)
		Hsa_circ_0003159	Tian et al. (2017)
		Hsa_circ_0000190	Chen et al. (2017c)
		CircPVT1	Chen et al. (2017a)
	CRC	Hsa_circ_001988	Wang et al. (2015a)
		Circ_001569	Xie et al. (2016)
		CircCCDC66	Hsiao et al. (2017)
		Hsa_circ_000984	Xu et al. (2017b)
	ESCC	Has_circ_0067934	Xia et al. (2016b)
		Cir-ITCH	Li et al. (2015a)
	HCC	CircZKSCAN1	Yao et al. (2017)
		CDRlas	Xu et al. (2017a)
		Hsa_circ_0005075	Shang et al. (2016)
		Hsa_circ_0004018	Fu et al. (2017)
		Hsa_circ_0001649	Qin et al. (2016)
		CircARSP91	Shi et al. (2017)
		Circ-10720	Meng et al. (2018)
		Circ-ITCH	Guo et al. (2017)
	Cervical Cancer	CDRlas	Lee et al. (2015)
	BC	Circ-Amotl1	Yang et al. (2017a)
	Human oral squamous cell carcinomas (OSCC)	Circrna_100290	Chen et al. (2017b)
	Lung adenocarcinoma (LAC)	Hsa_circ_0013958	Zhu et al. (2017)
	Bladder carcinoma	CircTCF25	Zhong, Lv & Chen (2016)
		CircPTK2	Xu et al. (2017c)